Catalyst Wire Dossier Catalyst Wire Dossier

Vectibix

panitumumab · Amgen
Drug timelines are a Plus or Pro feature.

46 regulatory and trial events tracked for Vectibix, covering 2006-09-27 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial) [Phase 2]

See pricing